Mandate

Vinge advises Gotlandsbolaget in connection with off-take agreement regarding biogas

February 17, 2025 Commercial Agreements M&A

Vinge has advised Rederiaktiebolaget Gotland (Gotlandsbolaget) in connection with the entry into of a strategic off-take agreement, which secures the long-term supply of biogas for the Gotland ferry service traffic.

Gotlandsbolaget aims to offer climate-neutral crossings between Gotland and the mainland by 2045. In order to do this, large volumes of fossil-free fuels are required. Vinge has advised Gotlandsbolaget in an investment in the construction of a biogas plant outside Eskilstuna for the production of high-quality biogas and the negotiation and execution of a 10-year off-take agreement regarding the purchase and delivery of the biogas produced. As a result of this transaction, Gotlandsbolaget has taken important steps towards achieving its goal of climate-neutral crossings between Gotland and the mainland. The plant is expected to be operational in 2026.

 

Vinge’s team consisted primarily of Malin Ohlin and Mario Saad.

Related

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025

Vinge has advised Boliden in connection with a directed share issue of SEK 3.75 billion

Vinge has advised Boliden AB in connection with a directed share issue through which the company raises proceeds of approximately SEK 3.75 billion before transaction costs.
March 21, 2025

Vinge advises EQT on its EUR 890 million sale of Dellner Couplers to Wabtec

Vinge together with Milbank advises the EQT VIII fund (“EQT”) on its sale of Dellner Couplers (“Dellner”), a leading provider of train connection systems for passenger rail, to Wabtec Corporation (a fortune 500 company listed on the New York Stock Exchange, NYSE: WAB). The transaction values Dellner at approximately EUR 890 million. The transaction is subject to customary conditions and regulatory approvals.
March 19, 2025